LOS ANGELES - November 19, 2019 - (Newswire.com)
QY Research has announced the addition of a new report to its medical devices and consumables archive of market research studies, titled “Global SPECT and SPECT-CT Market Research Report 2019.” According to the report, the global SPECT and SPECT-CT market was slightly more than US $1.40 billion in 2018 and is anticipated to reach above US $1.90 billion by 2025. The SPECT and SPECT-CT market is anticipated to exhibit a moderate CAGR of 4.64% by 2019-2025.
Increased adoption of SPECT/CT hybrid technology for diagnosis to stimulate market growth
SPECT/CT hybrid imaging systems are increasingly deployed for diagnosing, monitoring, and treating various diseases, which is a key factor driving the SPECT and SPECT-CT market. Recent technological advancements are expected to have a positive impact on the SPECT and SPECT-CT market growth. In addition, the increasing focus of manufacturers on the development of PET/MR hybrid imaging systems is expected to emerge as a key trend in the market in the near future.
Increasing applications of minimally invasive surgery are calling for the usage of hybrid SPECT/CT imaging to accurately define the diagnostic, as well as prognostic, profile of cardiovascular patients, thus positively influencing the market growth.
Get a PDF sample copy of this report: https://www.qyresearch.com/sample-form/form/1301409/global-spect-and-spect-ct-market
SPECT-CT to gain traction as a key diagnostic technology in the future
The type segments in the SPECT and SPECT-CT market include SPECT and SPECT-CT. SPECT-CT has been further segregated as Non Diagnostic, 4 Slice Diagnostic, 6 Slice Diagnostic, 8 Slice Diagnostic, 16 Slice Diagnostic, and others. SPECT-CT, also known as hybrid SPECT/CT imaging, is likely to gain traction, owing to its better attenuation correction, increased specificity, precise localization of disease, and improved diagnostic accuracy.
The report also provides a comprehensive analysis of the application segments, such as oncology, cardiology, neurology and others. Application of SPECT & SPECT-CT is expected to witness a surge in oncology due to its increased usage in the detection of coronary artery diseases and various other cardiac abnormalities.
North America to emerge as a frontrunner in the coming years
The increasing availability of new hybrid SPECT/CT devices with advanced technology in North America is one of the key factors expected to drive the SPECT and SPECT-CT market in the region. The presence of leading players in the U.S. is also anticipated to boost the SPECT and SPECT-CT market growth in this region. Also, well-established healthcare infrastructure may influence the market growth in North America to a great extent.
Players to perform extensive research and development in the years ahead
GE Healthcare, Siemens Healthineers, Philips Healthcare, Mediso, Spectrum Dynamics, Bruker, SurgicEye, MIE, and MILabs are some of the key manufacturers operating in the SPECT and SPECT-CT market. Manufacturers are carrying out extensive research and development pertaining to the newer diagnostic applications associated with SPECT-CT.
Related Links
Spectrum and Signal Analyzers Industry Research Report
Magnetic Resonance Spectroscopy (MRS) Market
Press Release Service by Newswire.com
Original Source: Global SPECT and SPECT-CT Market to Obtain Over US $1.90 Billion by 2025
